We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+17.28%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$942M
AUM Growth
+$65.9M
(+7.5%)
Cap. Flow
-$40.6M
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
1,095
New
434
Increased
124
Reduced
144
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$20.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.1M |
| 3 |
Qualcomm
QCOM
|
+$13.7M |
| 4 |
Datadog
DDOG
|
+$9.59M |
| 5 |
ExxonMobil
XOM
|
+$8.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$20M |
| 2 |
Meta Platforms (Facebook)
META
|
+$18.9M |
| 3 |
Walt Disney
DIS
|
+$11.5M |
| 4 |
Skyworks Solutions
SWKS
|
+$9.77M |
| 5 |
Nike
NKE
|
+$9.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.27% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 8.55% |
| 5 | Industrials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
676
Huya Inc
HUYA
$496M
| $58.1K | 0.01% |
+15,874
| New | +$53.1K |
|
|
FSR
677
DELISTED
Fisker Inc.
FSR
| $52K | 0.01% |
29,700
-203,300
| -87% | -$719K |
|
678
Lexicon Pharmaceuticals
LXRX
$1.02B
| $49.1K | 0.01% |
+32,119
| New | +$38.2K |
|
|
LILM
679
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $45.4K | ﹤0.01% |
38,450
-67,400
| -64% | -$61.4K |
|
680
Tilray
TLRY
$622M
| $43K | ﹤0.01% |
1,870
-18,894
| -91% | -$364K |
|
|
ME
681
DELISTED
23andMe Holding Co
ME
| $40K | ﹤0.01% |
+2,190
| New | +$37.9K |
|
682
CorMedix
CRMD
$641M
| $39.6K | ﹤0.01% |
+10,519
| New | +$36.2K |
|
|
SLGC
683
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $38.2K | ﹤0.01% |
+15,087
| New | +$35.1K |
|
684
RLX Technology
RLX
$2.24B
| $36.8K | ﹤0.01% |
+18,400
| New | +$34.2K |
|
|
ORLA
685
DELISTED
Orla Mining
ORLA
| $36.1K | ﹤0.01% |
+11,100
| New | +$34.9K |
|
686
Heron Therapeutics
HRTX
$61.9M
| $34.5K | ﹤0.01% |
+20,300
| New | +$22.4K |
|
687
X4 Pharmaceuticals
XFOR
$401M
| $33K | ﹤0.01% |
+1,313
| New | +$31.9K |
|
|
AMRN
688
Amarin Corp
AMRN
$295M
| $29.6K | ﹤0.01% |
+1,700
| New | +$26.7K |
|
689
Lloyds Banking Group
LYG
$85.6B
| $29.4K | ﹤0.01% |
+12,300
| New | +$26.3K |
|
|
PFIE
690
DELISTED
Profire Energy, Inc
PFIE
| $28.9K | ﹤0.01% |
+15,952
| New | +$30K |
|
|
MRSN
691
DELISTED
Mersana Therapeutics
MRSN
| $27.6K | ﹤0.01% |
+476
| New | +$19.1K |
|
|
MTTR
692
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $26.9K | ﹤0.01% |
10,000
-100
| -1% | -$240 |
|
693
Rigetti Computing
RGTI
$5.19B
| $25K | ﹤0.01% |
25,400
-8,300
| -25% | -$9.46K |
|
694
Rackspace Technology
RXT
$808M
| $21.2K | ﹤0.01% |
10,611
-31,089
| -75% | -$47K |
|
|
QVCGA
695
DELISTED
QVC Group Inc Series A
QVCGA
| $19.1K | ﹤0.01% |
+436
| New | +$14.9K |
|
696
Aclaris Therapeutics
ACRS
$883M
| $18.7K | ﹤0.01% |
+17,800
| New | +$54.3K |
|
697
Rigel Pharmaceuticals
RIGL
$857M
| $16.5K | ﹤0.01% |
1,138
-370
| -25% | -$3.78K |
|
|
TSP
698
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $15.2K | ﹤0.01% |
17,300
-8,000
| -32% | -$8.18K |
|
699
Precigen
PGEN
$2.49B
| $15.1K | ﹤0.01% |
+11,300
| New | +$13.3K |
|
700
D-Wave Quantum Inc
QBTS
$6.23B
| $14.3K | ﹤0.01% |
+16,200
| New | +$14.4K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Bayesian Capital Management held 1,095 positions worth $942M, up 7.5% from $876M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bayesian Capital Management withdrew a net $40.6M in Q4 2023, closing 391 positions and reducing 144 holdings. Its most notable exit was Palo Alto Networks, an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $21.5M.
- Bayesian Capital Management's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 45,200 shares worth $21.5M.
- Bayesian Capital Management added most to Alibaba in Q4 2023, an estimated $20.3M increase.
- Bayesian Capital Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $18.9M.
- Bayesian Capital Management fully exited Palo Alto Networks in Q4 2023, selling an estimated $20M.
- Bayesian Capital Management's ten largest holdings make up 18% of its $942M portfolio in Q4 2023.
- Bayesian Capital Management opened 434 new positions and closed 391 in Q4 2023.
- Bayesian Capital Management's portfolio value rose 7.5% quarter-over-quarter to $942M.
Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.